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Objective
To investigate the prevalence of urgency urinary incontinence
(UUI) at age 68 years and the contribution of vascular risk
factors to male and female UUI pathogenesis in addition to
the associations with raised body mass index (BMI).
Subjects and methods
In all, 1 762 participants from the Medical Research
Council (MRC) National Survey for Health and
Development birth cohort who answered the International
Consultation on Incontinence Questionnaire short form
(ICIQ-SF), at age 68 years, were included. Logistic
regression was used to estimate associations between UUI
and earlier life vascular risk factors including: lipid status,
diabetes, hypertension, BMI, previous stroke or transient
ischaemic attack (TIA) diagnosis; adjusting for smoking
status, physical activity, co-presentation of stress UI
symptoms, educational attainment; and in women only,
type of menopause, age at period cessation, and use of
hormone replacement therapy (HRT).
Results
UUI was reported by 12% of men and 19% of women at age
68 years. Female sex, previous stroke or TIA diagnosis,
increased BMI and hypertension (in men only) at age 60–
64 years were independent risk factors for UUI. Female sex,
increased BMI, and a previous diagnosis of stroke/TIA
increased the relative risk of more severe UUI symptoms.
Type and timing of menopause and HRT use did not alter
the estimated associations between UUI and vascular risk
factors in women.
Conclusion
Multifactorial mechanisms lead to UUI and vascular risk
factors may contribute to the pathogenesis of bladder
overactivity in addition to higher BMI. Severe UUI appears to
be a distinct presentation with more speciﬁc contributory
mechanisms than milder UUI.
Keywords
urgency, urinary incontinence, vascular, adiposity, prevalence,
ageing, #incontinence
Introduction
Urgency urinary incontinence (UUI) is involuntary loss of
urine associated with urgency (a sudden compelling desire
to pass urine that is difﬁcult to defer) [1], commonly
presenting with urinary frequency and nocturia as part of
the overactive bladder (OAB) syndrome. UUI is common:
prevalence of 30% has previously been reported for those
aged >65 years [2,3]. The actual prevalence of UUI is likely
to be even higher, as many older people may be too
embarrassed to report symptoms [4,5]. Greater frequency
or severity of UUI symptoms are associated with worse
quality of life [2,6–8] and increased risk of depression [9],
negatively impacting social interactions, relationships, and
self-esteem [10]. The cost of OAB syndrome in the UK
alone is currently estimated at £800 million/year, with a
further 22% increase anticipated by 2020 as a result of
medications, increased need for social care, and higher risk
of admission to a nursing home [11].
The multifactorial causes of UUI are reﬂected in the wide
range of risk factors identiﬁed in cross-sectional and
longitudinal studies. These include increasing age [12],
diagnosis of depression [13], alcohol intake [14], and
limitations in physical capability [15]. In addition, increased
body mass index (BMI) has been consistently associated with
all types of UI, including UUI in a number of cohorts [16–
18]. It is understood that central adiposity increases intra-
abdominal and bladder pressure in stress UI (SUI) and to a
lesser extent in UUI [3]. However, increased BMI is also
commonly associated with vascular risk factors, such as
insulin resistance and glucose intolerance, dyslipidaemia and
hypertension, as part of the metabolic syndrome [19]. As
such, vascular mechanisms may contribute to UUI
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pathophysiology at the peripheral and central nervous
systems, as well as directly on the detrusor muscle and pelvic
soft tissue.
Although UUI impacts a signiﬁcant proportion of both sexes
in the population, risk factors for UUI have mostly been
explored in cross-sectional samples of women [17,18,20–22].
In the present study, we investigated vascular risk factors
assessed at age 60–64 years and UUI subsequently ascertained
in men and women at age 68 years within a birth cohort,
taking account of a number of clinical and socio-behavioural
factors. We addressed four main questions:
1 What is the prevalence of male and female UI subtypes at
age 68 years?
2 Do vascular risk factors contribute to male and female UUI
in addition to the effects of raised BMI?
3 Is there evidence for a central neurological contribution to
UUI, through the additional contribution of a stroke/TIA
diagnosis over and above vascular risk factors in general?
4 Are the same vascular risk factors observed in association
with severe and mild UUI?
Subjects and Methods
The MRC National Survey for Health and Development
(NSHD) is the oldest British birth cohort study, following a
sample of 5 362 male and female participants, born in 1 week
in March 1946. During the 24th data collection in 2014–2015,
2 942 participants in the target sample living in England,
Scotland and Wales were contacted and 2 453 (83.4%)
returned a postal questionnaire. The target sample did not
include participants no longer in the study (n = 2 420): 957
(17.8% of the original sample) had already died, 620 (11.6%)
had previously withdrawn from the study, 448 (8.3%) had
emigrated and had no contact with the study, and 395 (7.4%)
had been untraceable for >5 years [23]. The 2 294
participants (93.5% of 2 453 who had returned a postal
questionnaire), whose symptoms reported on the postal
questionnaire corresponded to a recognised UI syndrome
were used as the maximum sample for analysis. Of these, 1
753 (76.4%) men and women had full covariate data (detailed
below), and comprised the complete sample.
Urinary Leakage
Questions on urinary leakage were based on the International
Consultation on Incontinence Questionnaire Short Form
(ICIQ-SF) [24]: ‘1. How often do you leak urine?’, ‘2. How
much urine do you usually leak?’, ‘3. How much does leaking
urine interfere with your everyday life, on a scale of 0 to 10?’.
Urinary symptoms were categorised into those with (i) UUI
only; (ii) SUI only; (iii) mixed UI (MUI). Participants with
UUI were deﬁned as those who reported urine leakage ‘before
you can get to the toilet’ or ‘when you are asleep’. Participants
with SUI were deﬁned by urine leakage ‘when you cough or
sneeze’ or ‘when you are physically active or exercising’. MUI
was deﬁned as responses with combination of SUI and UUI. A
severity score was calculated from the ICIQ-SF using the sum
of question 1, question 2 score multiplied by two and question
3, as recommended [24]. A severity score was not calculated
for 14 participants who did not respond to all three
components. UI severity was deﬁned as: no UI (score of 0),
mild UI (3–5), and more severe UI (≥6).
Vascular Exposures
At age 60–64 years, information was collected by a research
nurse at a home or clinic visit [25] on vascular risk factors
typically recognised as a component of the metabolic
syndrome [19]: lipid status, diabetes, hypertension, BMI, and
waist circumference. Hypertension was deﬁned as a doctor
diagnosis of hypertension, regular prescription of an anti-
hypertensive, or systolic blood pressure of >160 mmHg or
diastolic blood pressure >100 mmHg (taken from two
readings) [26]. Participants reported doctor-diagnosed type 1
or 2 diabetes mellitus. During the home or clinic visits, waist
circumference, height and weight were measured by
standardised protocols, and BMI was calculated (kg/m2). A
fasting blood sample was also taken during this home visit.
Lipid status was deﬁned according to whether the participant
was hypercholesterolaemic (total cholesterol >6 mM) and/or if
a cholesterol-lowering medication was prescribed. At age
68 years, participants reported any previous diagnosis of
stroke/transient ischaemic attack (TIA) ascertained by a
doctor.
Other Covariates
Other covariates selected included: smoking status (deﬁned as
current smoker, ex-smoker, or lifelong non-smoker, validated
against reports at earlier ages); co-presentation of SUI
symptoms at age 68 years; physical activity at age 60–
64 years, and educational attainment by the age of 26 years.
Educational attainment was categorised into: less than
ordinary secondary level; ‘O’ levels; advanced secondary level
(‘A’ level); and higher. Participants were asked how many
times in the last 4 weeks they had taken part in sports or
vigorous activities, categorised as inactive (no episodes), less
active (1–4 exercise episodes/month) and more active (≥5
exercise episodes/month). In women, we also accounted for
type of menopause (natural menopause, bilateral
oophorectomy or hysterectomy with at least one conserved
ovary), age at period cessation, and ever-use of hormone
replacement therapy (HRT) [27].
Statistical Analysis
First, using the maximum sample, the proportion of men and
women with UUI at age 68 years by each vascular risk factor
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and covariate was described. Logistic regression was used to
assess the strength of the associations for men and women
separately, testing for any sex interactions. Second, we
repeated the logistic regressions in 1 762 men and women
with complete covariate data, and made a series of three
adjustments: (i) for female sex, SUI, and previous diagnosis of
stroke/TIA; (ii) additionally for vascular risk factors; and (iii)
additionally for all other covariates. Analyses adjusted for
BMI per standard deviation (SD) rather than waist
circumference as the measure of adiposity; using both would
have resulted in collinearity. Third, we estimated multinomial
logistic regression models to compare risk factor proﬁles
between those with severe and mild UUI symptoms. Fourth,
we estimated logistic regression models to investigate the
associations of type and timing of menopause and HRT use
on UUI in women, to test whether any observed associations
between UUI and vascular risk factors could be accounted for
by menopause variables.
Results
Of 2 294 participants, 825 reported symptoms at age 68 years
consistent with a recognised UI subtype. For men, 15%
reported UI (UUI 12%, SUI 1.5%, MUI 1%); for women, 54%
reported UI (UUI 19% SUI 21% MUI 14%), demonstrating a
sex difference (P < 0.01). In men, 7% with an UI subtype had
severe symptoms, compared with 18% of women.
Co-presentation of SUI was associated with UUI in both
sexes, but was stronger in men than women (men = odds
ratio [OR] 5.3, 95% CI: 2.4–11.4; women = OR 1.6, 95% CI:
1.2–2.0; Table 1). Those diagnosed with a previous stroke or
TIA reported more UUI (26.3% vs 12.5% for men [OR 2.6,
95% CI: 1.4–4.8]; 47.5% vs 32.6% for women [OR 1.9, 95%
CI: 1.0–3.6]). A diagnosis of hypertension was associated with
an increased UUI risk in men and women; diabetes was
associated with an increased UUI risk in men but not in
women (sex interactions with hypertension P = 0.49, with
diabetes, P = 0.03). Raised BMI was associated with increased
UUI risk in men and women. No associations between
physical activity and UUI were evident.
Univariate models in those with complete data conﬁrmed that
being female, SUI symptoms, a previous stroke or TIA
diagnosis, increased BMI, hypertension and diabetes (in men
only) continued to be associated with higher odds of UUI
(Table 2, model 1). There were no associations between
smoking status, educational attainment or physical activity
and UUI. After adjusting for sex, SUI and any stroke or TIA
diagnosis the ORs for the other vascular factors were
attenuated but independent associations with BMI and
hypertension remained (model 2). In the fully adjusted
model, being female (OR 4.12, 95% CI: 2.49–6.82; P ≤ 0.01),
co-presentation of SUI (OR 1.8, 95% CI: 1.36–2.37; P ≤ 0.01),
having had a stroke or TIA diagnosis (OR 1.99, 95% CI:
1.14–3.49, P < 0.01) and increased BMI (OR 1.19 per SD, 95%
CI: 1.05–1.34; P = 0.01) were independent risk factors for
UUI.
A previous diagnosis of stroke/TIA increased the relative risk
of severe UUI symptoms (relative risk ratio [RRR] 3.65, 95%
CI: 1.87–7.1); no corresponding association was seen with
mild UUI. Increased BMI and being female were risk factors
for both mild and severe UUI (Table 3). There were no sex
interactions in these multivariate models. Type and timing of
menopause and HRT use did not alter the estimated
associations between UUI and vascular risk factors in women
(Table 4).
Discussion
In a large representative British population cohort at the age
of 68 years, the prevalence of UI was 15% in men (where
UUI was the most common subtype), and 54% in women
(with similar proportions of UUI and SUI subtypes). Female
sex, a previous diagnosis of stroke/TIA, increased BMI, and
SUI were associated with UUI symptoms. Stronger
associations were found between these risk factors and UUI if
severe UUI was reported. For those with milder symptoms,
the associations were weaker, except for the negative
association with educational attainment. In women, no
associations were found between UUI symptoms and
menopause or HRT use. Taken together, these results suggest
that vascular risk factors, in particular hypertension, may
contribute towards UUI pathophysiology in addition to
previous stroke/TIA, raised BMI, female sex and co-
presentation with SUI.
A strength of these analyses was the prospective
ascertainment of all variables. We used the ICIQ-SF, a
structured, validated scale with a speciﬁc component
evaluating impact on daily life. A limitation is the lack a
deﬁnite operationalisation of UI subtypes in ICIQ-SF,
excluding a small number of participants reporting only
atypical symptoms. Also, the severity of UI was measured
using self-reported symptom impact, without objective
urodynamic measures. Third, vascular covariates could not be
further characterised by cumulative exposure, such as
duration since ﬁrst diagnosis, introducing a dose-dependent
element to the associations. Lastly, the deﬁnition of previous
TIA/stroke did not differentiate between temporary or
permanent neurological deﬁcits, size of lesion or
neuroanatomical location of stroke.
Whilst the estimated prevalence of female UUI at the age of
68 years was similar to other studies with samples of similar
ages [21,22], UUI prevalence in men was higher than that
reported (11.7% for men aged >65 years, 95% CI: 9.27–
14.14%) in a recent pooled analysis of men aged >65 years
[28]. The increased prevalence of UUI in both men and
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women from age 53–68 years is consistent with previous
single and multicentre cross-sectional studies reporting
increasing age as a major risk factor for UUI [15,22,29]. The
prevalence of vascular risk factors in the NSHD was
comparable to published literature: the prevalence of diabetes
and hypertension at age 60–64 years were 6.9% and 38%,
respectively. In addition, 4.8% of participants had been
diagnosed with a stroke or reported TIA symptoms by the
age of 68 years. These are comparable to published literature:
the prevalence estimates of hypertension between 55 and
64 years was 45% according to the Health Survey for England
statistics report from 2012 [30]; 6.5% for diabetes at age 55–
64 years [31]; and 3% for men and 2% for women for
prevalence of stroke between 55 and 64 years using the
British Heart Foundation stroke statistics 2009 [32]. The
remaining discrepancies are likely explained by the 100%
White Caucasian demographics of the NSHD cohort, whilst
other analyses included participants of Afro-Caribbean and
South Asian ethnicities, where prevalence of hypertension and
diabetes respective are generally higher.
Our present ﬁndings suggest severe UUI to be a distinct
entity compared to mild UUI at this age, with more speciﬁc
risk factors. First, a syndrome of mild UUI possibly reﬂects
increased recognition of UUI symptoms as atypical for
normal ageing, with relatively less contribution of speciﬁc
vascular risk factors. In contrast, severe UUI is strongly
associated with previous stroke/TIA, which may result from a
greater contribution of vascular disease and central nervous
pathology. Patients with central lesions, such as strokes and
multiple sclerosis, commonly report UUI as a complication.
Structurally, subcortical white matter lesions, a marker of
chronic vascular burden, are associated with increased
symptoms of detrusor overactivity [33]. However, central
pathology can contribute to UUI even in the absence of overt
signs of neurological disease [34]: functional MRI studies
involving patients with UUI without diagnosed neurological
pathology have associated UUI symptoms with abnormal
activation patterns in the prefrontal and anterior cingulate
cortex, insula, basal ganglia, and cerebellum [34].
Whilst the present study corroborates previous ﬁndings that
BMI plays a central role in the aetiology of UUI [16,17], our
results also support the emerging view that obesity
contributes to UUI as part of a wider metabolic syndrome.
This is shown in men but not so in women. The association
between type 2 diabetes and male UUI in our present study is
consistent with previous studies linking UUI with markers of
poor glycaemic control, including diagnosis of type 2 diabetes
mellitus [35], higher glycated haemoglobin (HbA1c) in
patients with type 2 diabetes [36], raised serum insulin, and
increased homeostatic model assessment of insulin resistance
(HOMA-IR) [20]. Our association of hypertension and UUI
adds to a previous study linking hypertension with OAB
symptoms in a female cohort [14] (Figure 1).Ta
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Vascular risk factors for urge urinary incontinence
The present study provides prevalence of UI subtypes for
men and women within a representative large cohort in their
late 60s. We demonstrate that severe UUI is a distinct disease
entity, whilst those with milder UUI may represent a broad
range of contributory mechanisms. Our present ﬁndings
suggest that multifactorial mechanisms lead to UUI and that
vascular risk factors are additionally associated, potentially
playing a role in the development of pathological bladder
overactivity.
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Table 3 Multinomial regression analyses of RRRs in mild and severe UUI in 1 761 participants from the NSHD with complete data for vascular risk factors
and UI severity scores.
Adjusted for all covariates
Mild UUI Severe UUI
N = 1 748 RRR 95% CI P RRR 95% CI P
Female sex 3.51 2.58 4.77 <0.01 4.96 3.25 7.58 <0.01
Any stroke/TIA diagnosis by age 68 years 1.08 0.49 2.40 0.84 3.65 1.87 7.10 <0.01
Hypertension at age 60–64 years 1.21 0.90 1.63 0.21 1.31 0.89 1.91 0.17
Diabetes by age 60–64 years 0.96 0.52 1.78 0.89 1.18 0.60 2.34 0.63
Lipid and statin status at 60–64 years
No statins, normal LDLs 0.95 0.70 1.28 0.72
No statins, raised LDLs 0.93 0.61 1.42 0.74 0.66 0.44 0.99 0.05
Prescribed statins, normal LDLs 0.82 0.49 1.38 0.46
BMI at age 60–64 years 1.13 0.98 1.30 0.09 1.32 1.12 1.57 <0.01
Smoking status at age 60–64 years
Current Ref Ref
Ex-smoker 1.34 0.82 2.20 0.24 1.19 0.67 2.13 0.55
Never 1.37 0.82 2.29 0.23 0.71 0.37 1.35 0.30
LDLs, low-density lipoproteins. Bold highlights signiﬁcant ﬁndings.
Table 4 ORs for UUI in female NSHD participants with complete data for women’s health and vascular risk variables.
Variable, n = 752 Univariate (complete n) Adjusted for all covariates
OR 95% CI P OR 95% CI P
Type of menopause
Natural Ref 0.29 Ref
Hysterectomy 1.25 0.83 1.88 1.65 0.94 2.88 0.08
Bilateral oophorectomy 1.38 0.85 2.26 1.54 0.89 2.64 0.12
Period cessation age (years)
Natural 1.30 0.80 2.09 0.29 1.28 0.79 2.08 0.32
Hysterectomy 1.17 0.61 2.24 0.64 1.16 0.60 2.25 0.67
Bilateral Oophorectomy 2.09 0.81 5.39 0.13 2.17 0.83 5.67 0.11
Ever used HRT
Natural 0.92 0.65 1.32 0.59 0.89 0.62 1.28 0.53
Hysterectomy 0.66 0.27 1.63 0.48 0.74 0.29 1.88 0.53
Bilateral oophorectomy 3.66 0.41 32.95 0.24 4.83 0.47 49.36 0.18
Any SUI symptoms at age 68 years 1.60 1.17 2.19 <0.01 1.58 1.14 2.17 0.01
Any stroke/TIA diagnosis by age 68 years 1.79 0.78 4.11 0.17 1.60 0.67 3.82 0.29
Hypertension at age 60–64 years 1.26 0.92 1.73 0.15 1.13 0.80 1.59 0.48
Diabetes by age 60–64 years 1.00 0.50 1.98 0.99 0.76 0.35 1.64 0.48
Lipid and statin status at age 60–64 years 0.37 0.33
Normal LDLs Ref Ref
No statins, raised LDLs 0.79 0.57 1.10 0.81 0.58 1.13
Prescribed statins, normal LDLs 0.86 0.54 1.38 0.74 0.44 1.25
BMI at age 60–64 years 1.17 1.02 1.34 0.02 1.14 0.99 1.33 0.07
LDLs, low-density lipoproteins. Bold highlights signiﬁcant ﬁndings.
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